1. Home
  2. CADL vs GSBC Comparison

CADL vs GSBC Comparison

Compare CADL & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$9.46

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Logo Great Southern Bancorp Inc.

GSBC

Great Southern Bancorp Inc.

HOLD

Current Price

$79.69

Market Cap

811.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
GSBC
Founded
1999
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
694.6M
811.3M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
CADL
GSBC
Price
$9.46
$79.69
Analyst Decision
Strong Buy
Hold
Analyst Count
7
1
Target Price
$19.00
$65.00
AVG Volume (30 Days)
1.4M
106.6K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
2.54%
EPS Growth
58.62
17.68
EPS
N/A
1.58
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.56
P/E Ratio
N/A
$50.16
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$53.76
52 Week High
$11.36
$82.40

Technical Indicators

Market Signals
Indicator
CADL
GSBC
Relative Strength Index (RSI) 50.20 60.33
Support Level $9.19 $75.20
Resistance Level $11.36 $81.92
Average True Range (ATR) 0.58 2.61
MACD -0.07 -0.14
Stochastic Oscillator 24.29 69.87

Price Performance

Historical Comparison
CADL
GSBC

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.

Share on Social Networks: